Deubiquitinating Enzymes As Oncotargets
Overview
Authors
Affiliations
Carcinogenesis is a complex process tightly regulated at multiple levels by post-translational modifications. Epigenetics plays a major role in cancer development, all stable changes to the gene expression process that are not a result of a direct change in the DNA code are described as epigenetics. Epigenetic processes are regulated by post-translational modifications including ubiquitination which can directly affect either histones or transcription factors or may target their co-factors and interacting partners exerting an indirect effect. Deubiquitination of these target proteins is equally important and alterations in this pathway can also lead to cancer development, progression and metastasis. Only the correct, unaltered balance between ubiquitination and deubiquitination ensures healthy cellular homeostasis. In this review we focus on the role of deubiquitinating (DUB) enzymes in various aspects of epigenetics including the regulation of transcription factors, histone modifications, DNA damage repair pathways and cell cycle regulation. We discuss the impact of those processes on tumourigenesis and potential therapeutic applications of DUBs for cancer treatment.
Liu Y, Xun W, Zhao T, Huang M, Sun L, Wen G Commun Biol. 2024; 7(1):1365.
PMID: 39433916 PMC: 11494179. DOI: 10.1038/s42003-024-07051-2.
The roles of FGFR3 and c-MYC in urothelial bladder cancer.
Bogale D Discov Oncol. 2024; 15(1):295.
PMID: 39031286 PMC: 11264706. DOI: 10.1007/s12672-024-01173-z.
The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer.
Ye Z, Yang J, Jiang H, Zhan X Front Endocrinol (Lausanne). 2023; 14:1220108.
PMID: 37795365 PMC: 10546409. DOI: 10.3389/fendo.2023.1220108.
Wang M, Han X, Yu T, Wang M, Luo W, Zou C Theranostics. 2023; 13(7):2263-2280.
PMID: 37153745 PMC: 10157730. DOI: 10.7150/thno.83340.
Ubiquitin specific peptidases and prostate cancer.
Guo Y, Cui S, Chen Y, Guo S, Chen D PeerJ. 2023; 11:e14799.
PMID: 36811009 PMC: 9939025. DOI: 10.7717/peerj.14799.